Blog

Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society

Photo of Marleen Kok from avl.nl

Jul 10, 2024, 05:38

Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society

Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X:

“Incredibly proud of my team The Netherlands Cancer Institute to be awarded with this extraordinary grant of 4.1 million eur from KWF Dutch Cancer Society. We will test in an international study whether chemo can be safely omitted in patients with stI TNBC with high TILs. Thanks TILs Working Group, KWF Dutch Cancer Society, EORTC Breast Cancer Group.”

Source: Marleen Kok/X

Associate Professor cancer chemotherapy clinical trial EORTC Breast Cancer Group KWF Dutch Cancer Society Marleen Kok OncoDaily Oncology The Netherlands Cancer Institute TILs TNBC triple-negative breast cancer tumor infiltrating lymphocytes

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology